3vu9: Difference between revisions

← Older edit

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
-The entry 3vu9 is ON HOLD
+==Crystal Structure of Psy3-Csm2 complex==
+<StructureSection load='3vu9' size='340' side='right'caption='[[3vu9]], [[Resolution|resolution]] 1.75&Aring;' scene=''>
-Authors: Tawaramoto, M., Sasanuma, H., Hosaka, H., Lao, J.P., Sanda, E., Suzuki, M., Yamashita, E., Hunter, N., Shinohara, M., Nakagawa, A., Shinohara, A.
+== Structural highlights ==
+<table><tr><td colspan='2'>[[3vu9]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Saccharomyces_cerevisiae_S288C Saccharomyces cerevisiae S288C]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3VU9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3VU9 FirstGlance]. <br>
-Description: Crystal Structure of Psy3-Csm2 complex
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.75&#8491;</td></tr>
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3vu9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3vu9 OCA], [https://pdbe.org/3vu9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3vu9 RCSB], [https://www.ebi.ac.uk/pdbsum/3vu9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3vu9 ProSAT]</span></td></tr>
+</table>
+== Function ==
+[https://www.uniprot.org/uniprot/PSY3_YEAST PSY3_YEAST] Required for resistance to the DNA-damaging agents methyl methanesulfonate (MMS), cisplatin and oxaliplatin, but not to mitomycin C. Plays a role in protection against mutation accumulation. May be a component of the recombination-repair pathway.<ref>PMID:12149442</ref> <ref>PMID:12482937</ref> <ref>PMID:12972632</ref> <ref>PMID:15173006</ref> <ref>PMID:15654096</ref> <ref>PMID:19496932</ref>
+== References ==
+<references/>
+__TOC__
+</StructureSection>
+[[Category: Large Structures]]
+[[Category: Saccharomyces cerevisiae S288C]]
+[[Category: Hosaka H]]
+[[Category: Hunter N]]
+[[Category: Lao JP]]
+[[Category: Nakagawa A]]
+[[Category: Sanda E]]
+[[Category: Sasanuma H]]
+[[Category: Shinohara A]]
+[[Category: Shinohara M]]
+[[Category: Suzuki M]]
+[[Category: Tawaramoto M]]
+[[Category: Yamashita E]]